These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27663504)

  • 1. BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Lindner AU; Salvucci M; Morgan C; Monsefi N; Resler AJ; Cremona M; Curry S; Toomey S; O'Byrne R; Bacon O; Stühler M; Flanagan L; Wilson R; Johnston PG; Salto-Tellez M; Camilleri-Broët S; McNamara DA; Kay EW; Hennessy BT; Laurent-Puig P; Van Schaeybroeck S; Prehn JHM
    Gut; 2017 Dec; 66(12):2141-2148. PubMed ID: 27663504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea.
    Lindner AU; Resler AJ; Carberry S; Oficjalska K; Bacon O; Lee CS; Choudhry A; Burke JP; Sheahan K; Cremona M; Hennessy BT; McNamara D; Doherty G; Ryan EJ; Prehn JHM
    J Mol Med (Berl); 2020 Jan; 98(1):149-159. PubMed ID: 31848663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer.
    Salvucci M; Würstle ML; Morgan C; Curry S; Cremona M; Lindner AU; Bacon O; Resler AJ; Murphy ÁC; O'Byrne R; Flanagan L; Dasgupta S; Rice N; Pilati C; Zink E; Schöller LM; Toomey S; Lawler M; Johnston PG; Wilson R; Camilleri-Broët S; Salto-Tellez M; McNamara DA; Kay EW; Laurent-Puig P; Van Schaeybroeck S; Hennessy BT; Longley DB; Rehm M; Prehn JH
    Clin Cancer Res; 2017 Mar; 23(5):1200-1212. PubMed ID: 27649552
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway.
    Lathwal A; Arora C; Raghava GPS
    PLoS One; 2019; 14(9):e0217527. PubMed ID: 31498794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
    Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
    Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
    Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
    Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients.
    Wang X; Cao Y; Ding M; Liu J; Zuo X; Li H; Fan R
    Int J Med Sci; 2021; 18(7):1721-1729. PubMed ID: 33746588
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
    Huang B; Liu X; Sun C; Wang L; Yang L
    Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
    Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
    PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell lymphoma 2 and β-catenin expression in colorectal cancer and their prognostic role following surgery.
    Balzi M; Ringressi MN; Faraoni P; Booth C; Taddei A; Boni L; Bechi P
    Mol Med Rep; 2015 Jul; 12(1):553-60. PubMed ID: 25738398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
    Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.
    Carberry S; D'Orsi B; Monsefi N; Salvucci M; Bacon O; Fay J; Rehm M; McNamara D; Kay EW; Prehn JHM
    Cell Death Dis; 2018 Jan; 9(2):125. PubMed ID: 29374142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Bax/Bcl-2 ratio considered as a prognostic marker with age and tumor location in colorectal cancer?
    Khodapasand E; Jafarzadeh N; Farrokhi F; Kamalidehghan B; Houshmand M
    Iran Biomed J; 2015; 19(2):69-75. PubMed ID: 25864810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer.
    Wang X; Jiang Z; Zhang Y; Wang X; Liu L; Fan Z
    Oncotarget; 2017 Mar; 8(13):21984-21993. PubMed ID: 28423541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer.
    O'Cathail SM; Wu CH; Lewis A; Holmes C; Hawkins MA; Maughan T
    Cancer Genet; 2020 Oct; 248-249():1-10. PubMed ID: 32871287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.